| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |